The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Show more...
FAQ
ALPS Medical Breakthroughs 今天的股价是多少?▼
SBIO 当前价格为 $52.51 USD,过去 24 小时上涨了 +2.46%。在图表上更密切关注 ALPS Medical Breakthroughs 股价表现。
ALPS Medical Breakthroughs 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,ALPS Medical Breakthroughs 的股票以代码 SBIO 进行交易。
ALPS Medical Breakthroughs 的股价在上涨吗?▼
SBIO 股票较上周下跌 -1.02%,本月上涨 +4.69%,过去一年 ALPS Medical Breakthroughs 上涨 +61.27%。
ALPS Medical Breakthroughs 会发放股息吗?▼
是的,SBIO 的股息每 年度 发放一次。每股最新股息为 1.17 USD。截至今日,股息率(FWD)% 为 0%。
ALPS Medical Breakthroughs 何时完成拆股?▼
ALPS Medical Breakthroughs 最近没有进行任何拆股。